ALEXANDRIA, Virginia—The National Home Infusion Association (NHIA) released the Infusion Industry Trends, the latest assessment of the home and alternate site infusion industry’s market position. Based on claims data from a three year timeframe, this focused analysis shows how the industry is evolving across therapy categories and payer environments. The report also provides insight into emerging market dynamics, operations pressures and strategic opportunities.
“Home and alternate site infusion continues to demonstrate resilience and adaptability amid the evolving demands of care delivery," said NHIA CEO and President Connie Sullivan. "With a growing pipeline of complex infused therapies and continued emphasis on value, home infusion is playing a more central role in improving access, quality and system efficiency. At the same time, the report findings underscore meaningful opportunities to better align policy with the realities of modern infusion care—particularly with Medicare.”
The report groups therapies offered by providers into five categories (anti-infectives, home enteral nutrition, parenteral nutrition, specialty infusion and immune globulin) to provide a broad view. It also uses data to draw out the differences in reimbursement between commercial payers and Medicare and highlights the areas in which Medicare coverage is fragmented and incomplete. Specifically, one section offers a review of the Medicare home infusion benefit, including the complexity of coverage for the products that fall under that benefit and how the lack of comprehensive coverage results in reduced provider participation—ultimately impeding beneficiary access to care.
“This report is an essential tracking and strategic planning tool for every NHIA member,” said Greg LoPresti, chair of the NHIA board of directors and CEO of Upstate HomeCare.
The report is available for free to NHIA members and can be purchased by non-members at nhia.org/trends.